{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-017910","form_type":"8-K","ticker":"DH","cik":"0001861795","company_name":"Definitive Healthcare Corp.","filed_at":"2023-05-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:41.341487+00:00","generated_at":"2026-06-15T23:04:03.635594+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Definitive Healthcare Q1 revenue $59.2M (+18% YoY); net loss $15.6M","bullets":["Revenue $59.2M (+18% YoY from $50.1M); net loss $15.6M vs $13.1M prior year.","Adjusted net income $9.2M, up from $7.7M; adjusted EBITDA $15.7M (26% of revenue).","Q2 2023 guidance: revenue $60.5-$61.5M; full-year 2023 rev $249-255M (+12-15% YoY).","Launched DefinitiveConnect for Salesforce integration and Atlas AI analytics suite.","Enterprise customers: 529 with >$100K ARR; won deals with pharma, hospital, and non-profit clients."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-017910","json":"https://secwatch.observer/filing/0000950170-23-017910.json","markdown":"https://secwatch.observer/filing/0000950170-23-017910.md","text":"https://secwatch.observer/filing/0000950170-23-017910.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1861795/000095017023017910/0000950170-23-017910-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1861795/000095017023017910/dh-20230504.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-15T23:04:03.635594+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"72894fe8ef0f9c835b65d7450514f404ff40b6b8","claim":"Definitive Healthcare Corp. reported the quarter ended March 31, 2023 results: revenue $59.2 million, net income ($15.6) million.","evidence_excerpt":"--- EX-99 (EX-99.1) --- EX-99 Exhibit 99.1 Definitive Healthcare Reports Financial Results for First Quarter Fiscal Year 2023 First quarter revenue grew 18% year-over-year to $59.2 million Framingham, MA (May 4, 2023) – Definitive Healthcare Corp. (“Definitive Healthcare\" or the \"Company\") (Nasdaq: DH), an industry leader in healthcare commercial intelligence,","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1861795/000095017023017910/0000950170-23-017910-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the quarter ended March 31, 2023"},{"label":"Revenue","value":"$59.2 million"},{"label":"Net income","value":"($15.6) million"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}